Company Snapshot: VRML  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Vermillion to Webcast Presentation at The Roth Capital 2007 New York Conference

    FREMONT, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Vermillion, Inc.
(Nasdaq: VRML) announced today that it will webcast its presentation at the
Roth Capital 2007 New York Conference. Gail Page, President & CEO, will
provide a company overview at 5:00 p.m. Eastern on Wednesday, September 5,
2007.
    A webcast of the presentation will be available live and by replay. To
access both the live and archived webcast, please go to
http://www.vermillion.com and click on the "Investors" link. The archived
replay will be available for 24 hours after the live presentation and will
be accessible for 30 days.
    About Vermillion, Inc.
    Vermillion, Inc., is dedicated to the discovery, development and
commercialization of novel high-value diagnostic tests that help physicians
diagnose, treat and improve outcomes for patients. Vermillion, along with
its prestigious scientific collaborators, has ongoing diagnostic programs
in oncology/hematology, cardiology and women's health with an initial focus
in ovarian cancer. Based in Fremont, California, more information about
Vermillion can be found on the Web at http://www.vermillion.com


SOURCE Vermillion, Inc.




Back to Topback to top

Related links:
  • http://www.vermillion.com/
    CONTACT:
    Investor Relations, Sue Carruthers of
    Vermillion, Inc., +1-510-505-2233; or Media, Lori Murray,
    +1-415-946-1070, or Daryl Messinger, +1-415-946-1062, both of
    WeissComm Partners, for Vermillion, Inc.